---
title: "Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/271701431.md"
description: "Vertex Pharmaceuticals Inc. (VRTX) shares rose 4.36% to $468.38 on a strong trading day, breaking a six-day losing streak. The S&P 500 Index and Dow Jones Industrial Average also saw gains of 0.62% and 0.99%, respectively. Despite the rise, VRTX remains 9.87% below its 52-week high of $519.68. Competitors AbbVie Inc. (ABBV), Krystal Biotech Inc. (KRYS), and Arcturus Therapeutics Holdings Inc. (ARCT) also experienced stock increases, but VRTX outperformed them. Trading volume reached 2.1 million, surpassing its 50-day average of 1.4 million."
datetime: "2026-01-06T21:37:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271701431.md)
  - [en](https://longbridge.com/en/news/271701431.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271701431.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/271701431.md) | [English](https://longbridge.com/en/news/271701431.md)


# Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Vertex Pharmaceuticals Inc. (VRTX) rose 4.36% to $468.38 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.62% to 6,944.82 and the Dow Jones Industrial Average rising 0.99% to 49,462.08. The stock's rise snapped a six-day losing streak. Vertex Pharmaceuticals Inc. closed 9.87% below its 52-week high of $519.68, which the company achieved on March 14th. The stock outperformed some of its competitors Tuesday, as AbbVie Inc. (ABBV) rose 1.70% to $223.93, Krystal Biotech Inc. (KRYS) rose 1.91% to $249.39, and Arcturus Therapeutics Holdings Inc. (ARCT) rose 3.77% to $6.61. Trading volume (2.1 M) eclipsed its 50-day average volume of 1.4 M. Data source: Dow Jones Market Data, FactSet. Data compiled January 6, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 01-06-26 1637ET

### 相關股票

- [Vertex Pharma (VRTX.US)](https://longbridge.com/zh-HK/quote/VRTX.US.md)

## 相關資訊與研究

- [If You Invested $1000 In Vertex Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today](https://longbridge.com/zh-HK/news/281084218.md)
- [Vertex Pharmaceuticals Says US FDA Approves Label Expansion for Alyftrek, Trikafta](https://longbridge.com/zh-HK/news/281365753.md)
- [Vertex (VERX) launches tax engine and indirect tax accelerator on Oracle Marketplace](https://longbridge.com/zh-HK/news/281059587.md)
- [Vertex Advances FDA Filing for IgA Nephropathy Therapy](https://longbridge.com/zh-HK/news/281267382.md)
- [Vertex Pharmaceuticals Inc - FDA expands indication for trikafta in cf patients ages 2 and older](https://longbridge.com/zh-HK/news/281371049.md)